Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Capparelli

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Biological Chemistry|November 3, 2016
TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast CancerYing-Hui Ko, Marina Domingo-Vidal, Megan Roche, et al.
Nature Communications|November 5, 2025
Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma modelsConnor A Ott, Timothy J Purwin, Pan-Yu Chen, et al.
Nature Cell Biology|August 21, 2023
MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin loopingDan Filipescu, Saul Carcamo, Aman Agarwal, et al.
Cancer Research|July 31, 2025
Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T CellsSigne Caksa, Timothy J Purwin, Dan A Erkes, et al.
Nature Communications|March 17, 2022
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanomaClaudia Capparelli, Timothy J Purwin, McKenna Glasheen, et al.
The Journal of Clinical Investigation|September 16, 2025
Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanomaManoela Tiago, Timothy J Purwin, Casey D Stefanski, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Biological Chemistry|November 3, 2016
TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast CancerYing-Hui Ko, Marina Domingo-Vidal, Megan Roche, et al.
Nature Communications|November 5, 2025
Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma modelsConnor A Ott, Timothy J Purwin, Pan-Yu Chen, et al.
Nature Cell Biology|August 21, 2023
MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin loopingDan Filipescu, Saul Carcamo, Aman Agarwal, et al.
Cancer Research|July 31, 2025
Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T CellsSigne Caksa, Timothy J Purwin, Dan A Erkes, et al.
Nature Communications|March 17, 2022
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanomaClaudia Capparelli, Timothy J Purwin, McKenna Glasheen, et al.
The Journal of Clinical Investigation|September 16, 2025
Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanomaManoela Tiago, Timothy J Purwin, Casey D Stefanski, et al.
Pageof 3